As Vice President Global Late Phase Patricia Steigerwald provides executive leadership to drive continued growth in Kendle's Global Late Phase brand with a focus on the design and conduct of Phase IIIB/IV clinical trials health economics and outcomes research and product/disease registries.
Ms. Steigerwald has more than 20 years of CRO and clinical experience. Prior to joining Kendle she spent seven years with a leading CRO in a variety of positions in the late stage trials division serving most recently as Executive Director. In this position she had overall responsibility for the strategic direction of the division and the development of goals systems and procedures to ensure timely delivery of Phase IIIB/IV trials. Her experience also includes providing strategic guidance and oversight in the conduct of one of the world's largest global cardiovascular medical outcomes trials ever conducted. She has extensive experience in the oncology therapeutic area including a variety of studies involving melanoma small cell lung cancer and colon cancer.